Aim: To present the early experience with the implantation technique, safety and efficiency of STARflo device for open angle glaucoma (OAG).
Methods: referring intra- and postoperative clinical experience with a series of seven cases in three glaucoma centers in Hungary.
Results: No intraoperative complications were observed. Postoperative inflammatory signs disappeared rapidly. The mean IOP reduction was from 27.6 ± 5.0 mmHg to 18.9 ± 3.4 mmHg (32% reduction/ patient) at six months postoperatively.
Conclusion: STARflo implant was safe and (except for one case with neovascular glaucoma) effective in our cases. The learning curve for experienced anterior segment surgeons was short.